Alcidion Group (ASX:ALC) Is Up 8.7% After Returning To Profit On UK Healthcare IT Contracts

Simply Wall St.01-16

On 15 January 2026, Alcidion Group reported Q2 FY26 results showing a move from net loss to profit, backed by higher revenue, strong cash collections, a solid cash balance and no debt, underpinned by ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603960450?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-01-16 16:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603960450","market":"us","top_or_hot":-1,"title":"Alcidion Group (ASX:ALC) Is Up 8.7% After Returning To Profit On UK Healthcare IT Contracts","media":"Simply Wall St.","content":"<div>\n<p>On 15 January 2026, Alcidion Group reported Q2 FY26 results showing a move from net loss to profit, backed by higher revenue, strong cash collections, a solid cash balance and no debt, underpinned by ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/alcidion-group-asxalc-is-up-87-after-returning-to-profit-on\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alcidion Group (ASX:ALC) Is Up 8.7% After Returning To Profit On UK Healthcare IT Contracts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlcidion Group (ASX:ALC) Is Up 8.7% After Returning To Profit On UK Healthcare IT Contracts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-16 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/alcidion-group-asxalc-is-up-87-after-returning-to-profit-on><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On 15 January 2026, Alcidion Group reported Q2 FY26 results showing a move from net loss to profit, backed by higher revenue, strong cash collections, a solid cash balance and no debt, underpinned by ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/alcidion-group-asxalc-is-up-87-after-returning-to-profit-on\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALC","symbol_name":"Alcon Inc","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/alcidion-group-asxalc-is-up-87-after-returning-to-profit-on","article_id":"2603960450","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/alcidion-group-asxalc-is-up-87-after-returning-to-profit-on","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603960450","pubTimestamp":1768551699,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"On 15 January 2026, Alcidion Group reported Q2 FY26 results showing a move from net loss to profit, backed by higher revenue, strong cash collections, a solid cash balance and no debt, underpinned by sizeable multi‑year healthcare IT contracts and reaffirmed guidance for positive EBITDA and operating cash flow.\nA key insight is that recent UK contract wins, including preferred Electronic Patient Record supplier status and Miya Precision expansions, have materially increased contracted...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALC":"Alcon Inc","XBI":"SPDR S&P Biotech ETF","HCSG":"Healthcare Svcs Group Inc","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4198":"医疗保健用品","BK4588":"碎股","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK7094":"医疗保健技术","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XLV":"健康照护类股ETF-SPDR","BK4534":"瑞士信贷持仓","ALC.AU":"ALCIDION GROUP LTD","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4137":"综合支持服务","BK4585":"ETF&股票定投概念"},"translate_title":"Alcidion Group(ASX：ALC)在英国医疗保健IT合同恢复盈利后上涨8.7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALC":1.5,"ALC.AU":1.5,"XLV":1.5,"XBI":0.6,"HCSG":1.5,"LABU":0.6},"content_text":"On 15 January 2026, Alcidion Group reported Q2 FY26 results showing a move from net loss to profit, backed by higher revenue, strong cash collections, a solid cash balance and no debt, underpinned by sizeable multi‑year healthcare IT contracts and reaffirmed guidance for positive EBITDA and operating cash flow. A key insight is that recent UK contract wins, including preferred Electronic Patient Record supplier status and Miya Precision expansions, have materially increased contracted revenue out to FY26 and reinforced Alcidion’s position in large NHS digital transformation programs. We’ll now examine how this shift to profitability, supported by long-term UK healthcare contracts, may influence Alcidion’s existing investment narrative. Uncover the next big thing with financially sound penny stocks that balance risk and reward.AdvertisementAlcidion Group Investment Narrative RecapTo own Alcidion today, you need to believe it can turn its healthcare IT contracts, especially in the UK, into durable, cash generative growth while managing concentration and funding risks tied to the NHS. The Q2 FY26 move to profit, stronger cash collections and reaffirmed EBITDA and cash flow guidance support the near term profitability catalyst, but do not remove the key risk that large UK contracts and renewal timing can still create earnings volatility. The most relevant recent development here is Alcidion’s selection as preferred Electronic Patient Record supplier for a major UK trust, alongside Miya Precision expansions, which has lifted contracted revenue out to FY26 and strengthened its role in NHS digital programs. This reinforces the short term catalyst of improving earnings quality through higher recurring revenue, but it also deepens the company’s exposure to UK healthcare budgets and policy changes that investors should keep in mind. Yet behind the improving profitability and contract wins, investors still need to consider the growing dependence on UK NHS funding and... Read the full narrative on Alcidion Group (it's free!)Alcidion Group's narrative projects A$52.0 million revenue and A$2.9 million earnings by 2028. This requires 8.4% yearly revenue growth and about A$1.2 million earnings increase from A$1.7 million today.Uncover how Alcidion Group's forecasts yield a A$0.137 fair value, a 9% upside to its current price.Exploring Other PerspectivesASX:ALC 1-Year Stock Price Chart Three Simply Wall St Community valuations cluster between A$0.095 and A$0.14 per share, highlighting how differently private investors view Alcidion’s worth. You can weigh these opinions against the company’s expanding multi year UK contracts and the associated concentration risk for its future performance.Explore 3 other fair value estimates on Alcidion Group - why the stock might be worth as much as 12% more than the current price!Build Your Own Alcidion Group NarrativeDisagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.A great starting point for your Alcidion Group research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.Our free Alcidion Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Alcidion Group's overall financial health at a glance.Want Some Alternatives?Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:Find companies with promising cash flow potential yet trading below their fair value.These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.The latest GPUs need a type of rare earth metal called Neodymium and there are only 38 companies in the world exploring or producing it. Find the list for free.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603960450","isCrawlerRequest":true}